1.Xianglian Huazhuo Prescription Treats Chronic Atrophic Gastritis by Inhibiting Ferroptosis via Regulating lncRNA NOTCH1/miR-138-5p/SIRT1 Axis
Rui WANG ; Jiayuan XU ; Yican LIN ; Pengli DU ; Ziqi JIN ; Yanru CAI ; Yuxi GUO ; Qian YANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):39-50
ObjectiveTo construct a competing endogenous RNA (ceRNA) network involving long non-coding RNA NOTCH1 (lncRNA NOTCH1) and investigate whether Xianglian Huazhuo prescription (XLHZ) ameliorates gastric mucosal injury via regulating ferroptosis through the lncRNA NOTCH1/microRNA-138-5p (miR-138-5p)/silent information regulator 1 (SIRT1) axis. MethodsLncRNA sequencing and bioinformatics tools were used to construct the ceRNA network involving lncRNA NOTCH1. In the animal experiments, a chronic atrophic gastritis (CAG) model was induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in mice. Mice were randomized into normal, model, Morodan (2.0 g·kg-1), and high-, medium-, and low-dose (7.6, 3.8, 1.9 g·kg-1, respectively) XLHZ groups (n=10). Transmission electron microscopy was adopted to assess gastric pathology. Real-time PCR was employed to measure the mRNA levels of lncRNA NOTCH1, miR-138-5p, SIRT1, nuclear factor erythroid 2-related factor 2 (Nrf2), and glutathione peroxidase 4 (GPX4). Western blot was adopted to quantify the protein levels of SIRT1, Nrf2, and GPX4 in the gastric tissue. In the cell experiment, dual-luciferase assay was employed to verify the targeting among lncRNA NOTCH1, miR-138-5p, and SIRT1. MNNG was used to treat GES-1 cells for disease modeling. The effects of NOTCH1 mimics on the expression of lncRNA NOTCH1, miR-138-5p, and SIRT1, as well as the effects of miR-138-5p inhibitor on the expression of miR-138-5p and SIRT1, were observed. The rescue experiment with XLHZ was designed with five groups: GES-1, GES-1+MNNG (Model), Model+XLHZ, Model+NOTCH1 inhibitor+XLHZ, and Model+NOTCH1 inhibitor+miR-138-5p mimics+XLHZ. Real-time PCR and immunofluorescence assay were employed to measure the mRNA levels of lncRNA NOTCH1, miR-138-5p, SIRT1, Nrf2, and GPX4 and the Fe2+ content, respectively, in GES-1 cells. ResultsThe modeled mice showed mitochondrial damage with shrinkage and cristae loss, downregulated mRNA/protein levels of lncRNA NOTCH1, SIRT1, Nrf2, GPX4, and upregulated expression of miR-138-5p (P<0.01). Compared with the model group, drug treatments reduced mitochondrial structural damage and the membrane density decreased, partially recovered the crista structure, downregulated the expression of miR-138-5p, and upregulated the mRNA and protein levels of lncRNA NOTCH1, SIRT1, Nrf2, and GPX4 (P<0.05, P<0.01). In the cell experiments, the dual-luciferase assays confirmed lncRNA NOTCH1 bound to miR-138-5p and miR-138-5p bound to SIRT1, both suppressing luciferase activity (P<0.05, P<0.01). Compared with the blank control group, the model group showed decreased expression of lncRNA NOTCH1, SIRT1, Nrf2, GPX4, increased expression of miR-138-5p, and enhanced Fe2+ fluorescence (P<0.01). NOTCH1 mimics or miR-138-5p inhibitor reversed these changes (P<0.05, P<0.01). Rescue experiments showed that NOTCH1 inhibitor reversed XLHZ-induced miR-138-5p decrease and SIRT1 increase (P<0.01), while miR-138-5p overexpression suppressed SIRT1 expression (P<0.05, P<0.01). The results confirmed that lncRNA NOTCH1 negatively regulated miR-138-5p, which in turn negatively regulated SIRT1. ConclusionXLHZ effectively alleviates gastric mucosal injury and curbs CAG progression by inhibiting ferroptosis through modulation of the lncRNA NOTCH1/miR-138-5p/SIRT1 axis.
2.Xianglian Huazhuo Prescription Ameliorates Chronic Atrophic Gastritis via Regulating Lysosomal Iron Metabolism
Jiayuan XU ; Yican LIN ; Rui WANG ; Pengli DU ; Ziqi JIN ; Yanru CAI ; Yuxi GUO ; Qian YANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):65-75
ObjectiveTo explore the mechanism of Xianglian Huazhuo prescription (XLHZ) in ameliorating chronic atrophic gastritis (CAG) by regulating lysosomal iron metabolism. MethodsIn the animal experiments, a mouse model of CAG was established through a combined modeling approach, including free drinking of N-methyl-N′-nitro-N-nitrosoguanidine (MNNG, 100 mg·L-1), gavage of ranitidine (8 g·L-1), and irregular feeding. Mice were randomly assigned into the normal, model, Morodan (2.0 g·kg-1), and high-, medium-, and low-dose (7.2, 3.8, 1.9 g·kg-1, respectively) XLHZ groups. In the cell experiments, GES-1 cells were treated with MNNG to construct a cell model of CAG, and cells were allocated into the GES-1, GES-1+MNNG (Model), and Model+XLHZ groups. The general physical conditions of mice in each group were observed. Hematoxylin-eosin (HE) staining was used to detect the pathological morphology of the gastric mucosa. Transmission electron microscopy was employed to observe the ultrastructure of gastric mucosal cells. Enzyme-linked immunosorbent assay (ELISA) was adopted to measure the serum levels of interleukin-6 (IL-6), interleukin-1β (IL-1β), and interleukin-10 (IL-10) in the serum. Western blot was used to determine the protein levels of lysosome-associated membrane protein 1 (LAMP1), nuclear receptor coactivator 4 (NCOA4), ferritin heavy chain 1 (FTH1), six-transmembrane epithelial antigen of prostate 3 (Steap3), and transient receptor potential mucolipin 1 (TRPML1) in the gastric tissue. Immunohistochemistry was employed to detect the positive expression of glutathione peroxidase 4 (GPX4) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in the gastric tissue. Fluorescent probe method was used to detect the levels of Fe²⁺ and reactive oxygen species (ROS). Immunofluorescence assay was applied to observe the co-localization of FTH1 and LAMP1. ResultsThe animal experiments showed that compared with the normal group, the model group exhibited poor mental status and hair condition, accompanied by decreased locomotor activity, food and water intake, and even reduced body weight. HE staining results showed that the gastric mucosal epithelium of model mice presented poor continuity, significantly decreased mucosal thickness, irregular gastric fovea morphology with widened spacing, dilated glandular cavities, reduced and disarranged glands with obvious atrophy, and extensive inflammatory cell infiltration. Transmission electron microscopy revealed that the mitochondria were markedly shrunken with condensed and deeply stained matrix, drastically reduced and irregularly arranged cristae, and even vacuolization, and the outer mitochondrial membrane shrank and ruptured. In addition, the model group showed elevated serum levels of IL-6 and IL-1β (P<0.01), declined serum level of IL-10 (P<0.01), upregulated protein levels of LAMP1, NCOA4, Steap3, and TRPML1 (P<0.01), downregulated protein level of FTH1 (P<0.01) in the gastric tissue, reduced positive expression of GPX4 (P<0.01), and increased positive expression of 8-OHdG (P<0.01). Compared with the model group, all the treatment groups showed improved mental state and hair appearance, increased locomotor activity, food and water intake, as well as gradual body weight gain in mice. HE staining demonstrated that the gastric mucosal epithelium of mice in each treatment group was continuous and intact, with normalized gastric fovea morphology, narrowed glandular cavities, increased and neatly arranged glands, and alleviated inflammatory cell infiltration. Transmission electron microscopy results showed that the mitochondria in mice from each treatment group possessed intact structures with recovered normal volume, increased and regularly arranged cristae, and homogeneous density of the mitochondrial membrane. The mice treated with high and medium doses of XLHZ exhibited declined serum levels of IL-6 and IL-1β (P<0.01) and elevated serum level of IL-10 (P<0.01). Low-dose XLHZ reduced serum IL-1β level in mice (P<0.05). The expression levels of LAMP1, NCOA4, Steap3 and TRPML1 protein in gastric tissue of mice in XLHZ high- and medium-dose groups were decreased (P<0.05, P<0.01), and the expression level of FTH1 protein was increased (P<0.05, P<0.01). The positive expression of GPX4 in the gastric tissue was increased in the high- and medium-dose XLHZ groups (P<0.05, P<0.01), and that of 8-OHdG was decreased in all treatment groups (P<0.01). The cell experiments showed that compared with the GES-1 group, the fluorescence intensities of Fe²⁺ and ROS, as well as the co-localization of FTH1 and LAMP1, were significantly increased in the GES-1 + MNNG group (P<0.01). Compared with the GES-1 + MNNG group, the fluorescence intensities of Fe²⁺ and ROS were markedly decreased in the Model + XLHZ group (P<0.01), while the co-localization of FTH1 and LAMP1 was reduced (P<0.05). ConclusionXLHZ can effectively regulate lysosomal iron metabolism and ameliorate gastric mucosal and cellular injury induced by CAG.
3.Xianglian Huazhuo Prescription Treats Chronic Atrophic Gastritis by Inhibiting Ferroptosis via Regulating lncRNA NOTCH1/miR-138-5p/SIRT1 Axis
Rui WANG ; Jiayuan XU ; Yican LIN ; Pengli DU ; Ziqi JIN ; Yanru CAI ; Yuxi GUO ; Qian YANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):39-50
ObjectiveTo construct a competing endogenous RNA (ceRNA) network involving long non-coding RNA NOTCH1 (lncRNA NOTCH1) and investigate whether Xianglian Huazhuo prescription (XLHZ) ameliorates gastric mucosal injury via regulating ferroptosis through the lncRNA NOTCH1/microRNA-138-5p (miR-138-5p)/silent information regulator 1 (SIRT1) axis. MethodsLncRNA sequencing and bioinformatics tools were used to construct the ceRNA network involving lncRNA NOTCH1. In the animal experiments, a chronic atrophic gastritis (CAG) model was induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in mice. Mice were randomized into normal, model, Morodan (2.0 g·kg-1), and high-, medium-, and low-dose (7.6, 3.8, 1.9 g·kg-1, respectively) XLHZ groups (n=10). Transmission electron microscopy was adopted to assess gastric pathology. Real-time PCR was employed to measure the mRNA levels of lncRNA NOTCH1, miR-138-5p, SIRT1, nuclear factor erythroid 2-related factor 2 (Nrf2), and glutathione peroxidase 4 (GPX4). Western blot was adopted to quantify the protein levels of SIRT1, Nrf2, and GPX4 in the gastric tissue. In the cell experiment, dual-luciferase assay was employed to verify the targeting among lncRNA NOTCH1, miR-138-5p, and SIRT1. MNNG was used to treat GES-1 cells for disease modeling. The effects of NOTCH1 mimics on the expression of lncRNA NOTCH1, miR-138-5p, and SIRT1, as well as the effects of miR-138-5p inhibitor on the expression of miR-138-5p and SIRT1, were observed. The rescue experiment with XLHZ was designed with five groups: GES-1, GES-1+MNNG (Model), Model+XLHZ, Model+NOTCH1 inhibitor+XLHZ, and Model+NOTCH1 inhibitor+miR-138-5p mimics+XLHZ. Real-time PCR and immunofluorescence assay were employed to measure the mRNA levels of lncRNA NOTCH1, miR-138-5p, SIRT1, Nrf2, and GPX4 and the Fe2+ content, respectively, in GES-1 cells. ResultsThe modeled mice showed mitochondrial damage with shrinkage and cristae loss, downregulated mRNA/protein levels of lncRNA NOTCH1, SIRT1, Nrf2, GPX4, and upregulated expression of miR-138-5p (P<0.01). Compared with the model group, drug treatments reduced mitochondrial structural damage and the membrane density decreased, partially recovered the crista structure, downregulated the expression of miR-138-5p, and upregulated the mRNA and protein levels of lncRNA NOTCH1, SIRT1, Nrf2, and GPX4 (P<0.05, P<0.01). In the cell experiments, the dual-luciferase assays confirmed lncRNA NOTCH1 bound to miR-138-5p and miR-138-5p bound to SIRT1, both suppressing luciferase activity (P<0.05, P<0.01). Compared with the blank control group, the model group showed decreased expression of lncRNA NOTCH1, SIRT1, Nrf2, GPX4, increased expression of miR-138-5p, and enhanced Fe2+ fluorescence (P<0.01). NOTCH1 mimics or miR-138-5p inhibitor reversed these changes (P<0.05, P<0.01). Rescue experiments showed that NOTCH1 inhibitor reversed XLHZ-induced miR-138-5p decrease and SIRT1 increase (P<0.01), while miR-138-5p overexpression suppressed SIRT1 expression (P<0.05, P<0.01). The results confirmed that lncRNA NOTCH1 negatively regulated miR-138-5p, which in turn negatively regulated SIRT1. ConclusionXLHZ effectively alleviates gastric mucosal injury and curbs CAG progression by inhibiting ferroptosis through modulation of the lncRNA NOTCH1/miR-138-5p/SIRT1 axis.
4.Xianglian Huazhuo Prescription Ameliorates Chronic Atrophic Gastritis via Regulating Lysosomal Iron Metabolism
Jiayuan XU ; Yican LIN ; Rui WANG ; Pengli DU ; Ziqi JIN ; Yanru CAI ; Yuxi GUO ; Qian YANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):65-75
ObjectiveTo explore the mechanism of Xianglian Huazhuo prescription (XLHZ) in ameliorating chronic atrophic gastritis (CAG) by regulating lysosomal iron metabolism. MethodsIn the animal experiments, a mouse model of CAG was established through a combined modeling approach, including free drinking of N-methyl-N′-nitro-N-nitrosoguanidine (MNNG, 100 mg·L-1), gavage of ranitidine (8 g·L-1), and irregular feeding. Mice were randomly assigned into the normal, model, Morodan (2.0 g·kg-1), and high-, medium-, and low-dose (7.2, 3.8, 1.9 g·kg-1, respectively) XLHZ groups. In the cell experiments, GES-1 cells were treated with MNNG to construct a cell model of CAG, and cells were allocated into the GES-1, GES-1+MNNG (Model), and Model+XLHZ groups. The general physical conditions of mice in each group were observed. Hematoxylin-eosin (HE) staining was used to detect the pathological morphology of the gastric mucosa. Transmission electron microscopy was employed to observe the ultrastructure of gastric mucosal cells. Enzyme-linked immunosorbent assay (ELISA) was adopted to measure the serum levels of interleukin-6 (IL-6), interleukin-1β (IL-1β), and interleukin-10 (IL-10) in the serum. Western blot was used to determine the protein levels of lysosome-associated membrane protein 1 (LAMP1), nuclear receptor coactivator 4 (NCOA4), ferritin heavy chain 1 (FTH1), six-transmembrane epithelial antigen of prostate 3 (Steap3), and transient receptor potential mucolipin 1 (TRPML1) in the gastric tissue. Immunohistochemistry was employed to detect the positive expression of glutathione peroxidase 4 (GPX4) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in the gastric tissue. Fluorescent probe method was used to detect the levels of Fe²⁺ and reactive oxygen species (ROS). Immunofluorescence assay was applied to observe the co-localization of FTH1 and LAMP1. ResultsThe animal experiments showed that compared with the normal group, the model group exhibited poor mental status and hair condition, accompanied by decreased locomotor activity, food and water intake, and even reduced body weight. HE staining results showed that the gastric mucosal epithelium of model mice presented poor continuity, significantly decreased mucosal thickness, irregular gastric fovea morphology with widened spacing, dilated glandular cavities, reduced and disarranged glands with obvious atrophy, and extensive inflammatory cell infiltration. Transmission electron microscopy revealed that the mitochondria were markedly shrunken with condensed and deeply stained matrix, drastically reduced and irregularly arranged cristae, and even vacuolization, and the outer mitochondrial membrane shrank and ruptured. In addition, the model group showed elevated serum levels of IL-6 and IL-1β (P<0.01), declined serum level of IL-10 (P<0.01), upregulated protein levels of LAMP1, NCOA4, Steap3, and TRPML1 (P<0.01), downregulated protein level of FTH1 (P<0.01) in the gastric tissue, reduced positive expression of GPX4 (P<0.01), and increased positive expression of 8-OHdG (P<0.01). Compared with the model group, all the treatment groups showed improved mental state and hair appearance, increased locomotor activity, food and water intake, as well as gradual body weight gain in mice. HE staining demonstrated that the gastric mucosal epithelium of mice in each treatment group was continuous and intact, with normalized gastric fovea morphology, narrowed glandular cavities, increased and neatly arranged glands, and alleviated inflammatory cell infiltration. Transmission electron microscopy results showed that the mitochondria in mice from each treatment group possessed intact structures with recovered normal volume, increased and regularly arranged cristae, and homogeneous density of the mitochondrial membrane. The mice treated with high and medium doses of XLHZ exhibited declined serum levels of IL-6 and IL-1β (P<0.01) and elevated serum level of IL-10 (P<0.01). Low-dose XLHZ reduced serum IL-1β level in mice (P<0.05). The expression levels of LAMP1, NCOA4, Steap3 and TRPML1 protein in gastric tissue of mice in XLHZ high- and medium-dose groups were decreased (P<0.05, P<0.01), and the expression level of FTH1 protein was increased (P<0.05, P<0.01). The positive expression of GPX4 in the gastric tissue was increased in the high- and medium-dose XLHZ groups (P<0.05, P<0.01), and that of 8-OHdG was decreased in all treatment groups (P<0.01). The cell experiments showed that compared with the GES-1 group, the fluorescence intensities of Fe²⁺ and ROS, as well as the co-localization of FTH1 and LAMP1, were significantly increased in the GES-1 + MNNG group (P<0.01). Compared with the GES-1 + MNNG group, the fluorescence intensities of Fe²⁺ and ROS were markedly decreased in the Model + XLHZ group (P<0.01), while the co-localization of FTH1 and LAMP1 was reduced (P<0.05). ConclusionXLHZ can effectively regulate lysosomal iron metabolism and ameliorate gastric mucosal and cellular injury induced by CAG.
5.A Case of Hypocomplementemic Urticarial Vasculitis Treated with Tofacitinib
Lan GUO ; Chunxia HE ; Linyi PENG ; Yueping ZENG ; Min SHEN ; Jiayuan DAI
JOURNAL OF RARE DISEASES 2026;5(3):342-347
Hypocomplementemic urticarial vasculitis (HUV) is a rare autoimmune disorder characterized by recurrent urticarial eruptions, hypocomplementemia and systemic involvement. This disease is prone to misdiagnosis, and its systemic manifestations may include arthritis, abdominal pain, renal involvement, chronic obstructive pulmonary disease and so on. Herein, we report a case of HUV presenting with recurrent abdominal pain, generalized wheals and arthralgia. Laboratory tests revealed decreased complement levels, skin histopathology was consistent with leukocytoclastic vasculitis, and imaging examinations indicated spondyloarthritis, thus confirming the diagnosis of HUV. The patient initially received systemic glucocorticoids combined with colchicine, whereas recurrent rash and arthralgia persisted. Tofacitinib (a Janus kinase inhibitor) and methotrexate were subsequently added to the regimen, leading to remission of symptoms. This case suggests that tofacitinib may serve as a potential therapeutic alternative for patients with HUV who respond poorly to glucocorticoids.
6.Long noncoding RNA TP53TG1 promotes odontogenic and osteogenic differentiation of stem cells from the apical papilla
Tingyue LI ; Qian GUO ; Wenxi HE ; Jiayuan WU
Chinese Journal of Tissue Engineering Research 2025;29(36):7776-7782
BACKGROUND:Long noncoding RNA TP53TG1(lncRNA TP53TG1)is involved in regulating the proliferation,migration,invasion,and apoptosis of various cancer cells,but there are few reports on its role in other cells.OBJECTIVE:To investigate the effects and pathways of lncRNA TP53TG1 on the proliferation and differentiation of human stem cells from the apical papilla.METHODS:Human stem cells from the apical papilla were isolated and cultured,and then transfected with lncRNA TP53TG1 overexpression lentivirus.RT-qPCR was used to detect the overexpression efficiency of lncRNA TP53TG1.Western blot assay was used to detect the relative expression levels of PI3K,AKT,ERK,P38,Smad3,and their phosphorylated proteins.Human stem cells from the apical papilla were divided into the empty lentiviral vector transfection group and the lncRNA TP53TG1 overexpression group.CCK-8 assay was used to measure the cell proliferation.Alkaline phosphatase activity was detected by alkaline phosphatase staining on day 5 of osteogenic induction.Formation of mineralized nodules was detected by alizarin red staining on day 21 of osteogenic induction.RT-qPCR was used to detect the mRNA expression levels of dentin sialophosphoprotein,Runt-related transcription factor 2,dentin matrix protein 1,and bone sialoprotein on days 3,7,and 14 of osteogenic induction.Western blot assay was used to detect the protein expression levels of dentin sialophosphoprotein and Runt-related transcription factor 2 on days 3,7,and 14 of osteogenic induction.RESULTS AND CONCLUSION:(1)RT-qPCR results showed that the lentivirus was successfully integrated into the genome of stem cells from the apical papilla.Western blot assay results showed that overexpression of lncRNA TP53TG1 up-regulated the protein levels of p-PI3K and p-AKT without affecting the expression of phosphorylated proteins in other pathways.(2)Starting from day 3 of cell culture,overexpression of lncRNA TP53TG1 significantly promoted the proliferation of stem cells from the apical papilla.(3)In the process of inducing odontogenic differentiation of stem cells from the apical papilla,overexpression of lncRNA TP53TG1 promoted the expression of odontogenic and osteogenic differentiation-related genes and proteins,significantly increased alkaline phosphatase activity and mineralized nodule formation.(4)The results show that lncRNA TP53TG1 may promote the odontogenic and osteogenic differentiation of stem cells from the apical papilla by activating the PI3K/AKT signaling pathway.
7.Long noncoding RNA TP53TG1 promotes odontogenic and osteogenic differentiation of stem cells from the apical papilla
Tingyue LI ; Qian GUO ; Wenxi HE ; Jiayuan WU
Chinese Journal of Tissue Engineering Research 2025;29(36):7776-7782
BACKGROUND:Long noncoding RNA TP53TG1(lncRNA TP53TG1)is involved in regulating the proliferation,migration,invasion,and apoptosis of various cancer cells,but there are few reports on its role in other cells.OBJECTIVE:To investigate the effects and pathways of lncRNA TP53TG1 on the proliferation and differentiation of human stem cells from the apical papilla.METHODS:Human stem cells from the apical papilla were isolated and cultured,and then transfected with lncRNA TP53TG1 overexpression lentivirus.RT-qPCR was used to detect the overexpression efficiency of lncRNA TP53TG1.Western blot assay was used to detect the relative expression levels of PI3K,AKT,ERK,P38,Smad3,and their phosphorylated proteins.Human stem cells from the apical papilla were divided into the empty lentiviral vector transfection group and the lncRNA TP53TG1 overexpression group.CCK-8 assay was used to measure the cell proliferation.Alkaline phosphatase activity was detected by alkaline phosphatase staining on day 5 of osteogenic induction.Formation of mineralized nodules was detected by alizarin red staining on day 21 of osteogenic induction.RT-qPCR was used to detect the mRNA expression levels of dentin sialophosphoprotein,Runt-related transcription factor 2,dentin matrix protein 1,and bone sialoprotein on days 3,7,and 14 of osteogenic induction.Western blot assay was used to detect the protein expression levels of dentin sialophosphoprotein and Runt-related transcription factor 2 on days 3,7,and 14 of osteogenic induction.RESULTS AND CONCLUSION:(1)RT-qPCR results showed that the lentivirus was successfully integrated into the genome of stem cells from the apical papilla.Western blot assay results showed that overexpression of lncRNA TP53TG1 up-regulated the protein levels of p-PI3K and p-AKT without affecting the expression of phosphorylated proteins in other pathways.(2)Starting from day 3 of cell culture,overexpression of lncRNA TP53TG1 significantly promoted the proliferation of stem cells from the apical papilla.(3)In the process of inducing odontogenic differentiation of stem cells from the apical papilla,overexpression of lncRNA TP53TG1 promoted the expression of odontogenic and osteogenic differentiation-related genes and proteins,significantly increased alkaline phosphatase activity and mineralized nodule formation.(4)The results show that lncRNA TP53TG1 may promote the odontogenic and osteogenic differentiation of stem cells from the apical papilla by activating the PI3K/AKT signaling pathway.
8.Association of white blood cell count with venous thromboembo-lism:a two-way Mendelian randomization study
Zhanli GUO ; Yuan WANG ; Lei ZHANG ; Jiayuan LI ; Ruoning LI ; Ying DONG ; Jianjun SUN
Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(4):446-455
AIM:To explore the causal association between the counts of five types of white blood cells—neutrophils,monocytes,eosinophils,baso-phils,and lymphocytes—and venous thromboem-bolism(VTE).METHODS:Mendelian randomization(MR)analysis method was used,with genetic vari-ants associated with the five types of white blood cells as instrumental variables,and venous throm-boembolism occurrence risk as the outcome vari-able,inverse variance-weighted(IVW)method was employed as the primary analysis method,with MR-Egger regression,weighted median(WM),sim-ple model,and weighted mode methods used as supplements,to analyze the causal association be-tween the counts of five types of white blood cells and VTE,followed by reverse MR analysis.RE-SULTS:Neutrophil and lymphocyte counts are caus-ally associated with the risk of VTE.For neutrophil count,the IVW estimate(OR=0.867,95%CI:0.761-0.981,P=0.031),MR-Egger estimate(OR=0.754,95%CI:0.571-0.996,P=0.048),weighted median es-timate(OR=0.846,95%CI:0.729-0.981,P=0.027),and weighted model estimate(OR=0.748,95%CI:0.595-0.942,P=0.014)were calculated.For lympho-cyte count,the IVW estimate(OR=0.838,95%CI:0.741-0.949,P=0.005)and weighted median esti-mate(OR=0.024,95%CI:0.718-0.977,P=0.024)were calculated.Reverse MR analysis showed a causal association between the risk of VTE and neu-trophil count,the IVW estimate(OR=0.989,95%CI:0.980-0.999,P=0.024).CONCLUSION:Neutrophil and lymphocyte counts are related to the risk of VTE,and decrease in neutrophil and lymphocyte numbers may increase the risk of VTE.VTE occur-rence risk is associated with neutrophil count,and reducing the risk of VTE occurrence may increase neutrophil count.Further research is needed to un-derstand the underlying biological mechanisms be-hind this relationship.
9.Association of white blood cell count with venous thromboembo-lism:a two-way Mendelian randomization study
Zhanli GUO ; Yuan WANG ; Lei ZHANG ; Jiayuan LI ; Ruoning LI ; Ying DONG ; Jianjun SUN
Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(4):446-455
AIM:To explore the causal association between the counts of five types of white blood cells—neutrophils,monocytes,eosinophils,baso-phils,and lymphocytes—and venous thromboem-bolism(VTE).METHODS:Mendelian randomization(MR)analysis method was used,with genetic vari-ants associated with the five types of white blood cells as instrumental variables,and venous throm-boembolism occurrence risk as the outcome vari-able,inverse variance-weighted(IVW)method was employed as the primary analysis method,with MR-Egger regression,weighted median(WM),sim-ple model,and weighted mode methods used as supplements,to analyze the causal association be-tween the counts of five types of white blood cells and VTE,followed by reverse MR analysis.RE-SULTS:Neutrophil and lymphocyte counts are caus-ally associated with the risk of VTE.For neutrophil count,the IVW estimate(OR=0.867,95%CI:0.761-0.981,P=0.031),MR-Egger estimate(OR=0.754,95%CI:0.571-0.996,P=0.048),weighted median es-timate(OR=0.846,95%CI:0.729-0.981,P=0.027),and weighted model estimate(OR=0.748,95%CI:0.595-0.942,P=0.014)were calculated.For lympho-cyte count,the IVW estimate(OR=0.838,95%CI:0.741-0.949,P=0.005)and weighted median esti-mate(OR=0.024,95%CI:0.718-0.977,P=0.024)were calculated.Reverse MR analysis showed a causal association between the risk of VTE and neu-trophil count,the IVW estimate(OR=0.989,95%CI:0.980-0.999,P=0.024).CONCLUSION:Neutrophil and lymphocyte counts are related to the risk of VTE,and decrease in neutrophil and lymphocyte numbers may increase the risk of VTE.VTE occur-rence risk is associated with neutrophil count,and reducing the risk of VTE occurrence may increase neutrophil count.Further research is needed to un-derstand the underlying biological mechanisms be-hind this relationship.
10.Expert consensus on difficulty assessment of endodontic therapy
Huang DINGMING ; Wang XIAOYAN ; Liang JINGPING ; Ling JUNQI ; Bian ZHUAN ; Yu QING ; Hou BENXIANG ; Chen XINMEI ; Li JIYAO ; Ye LING ; Cheng LEI ; Xu XIN ; Hu TAO ; Wu HONGKUN ; Guo BIN ; Su QIN ; Chen ZHI ; Qiu LIHONG ; Chen WENXIA ; Wei XI ; Huang ZHENGWEI ; Yu JINHUA ; Lin ZHENGMEI ; Zhang QI ; Yang DEQIN ; Zhao JIN ; Pan SHUANG ; Yang JIAN ; Wu JIAYUAN ; Pan YIHUAI ; Xie XIAOLI ; Deng SHULI ; Huang XIAOJING ; Zhang LAN ; Yue LIN ; Zhou XUEDONG
International Journal of Oral Science 2024;16(1):15-25
Endodontic diseases are a kind of chronic infectious oral disease.Common endodontic treatment concepts are based on the removal of inflamed or necrotic pulp tissue and the replacement by gutta-percha.However,it is very essential for endodontic treatment to debride the root canal system and prevent the root canal system from bacterial reinfection after root canal therapy(RCT).Recent research,encompassing bacterial etiology and advanced imaging techniques,contributes to our understanding of the root canal system's anatomy intricacies and the technique sensitivity of RCT.Success in RCT hinges on factors like patients,infection severity,root canal anatomy,and treatment techniques.Therefore,improving disease management is a key issue to combat endodontic diseases and cure periapical lesions.The clinical difficulty assessment system of RCT is established based on patient conditions,tooth conditions,root canal configuration,and root canal needing retreatment,and emphasizes pre-treatment risk assessment for optimal outcomes.The findings suggest that the presence of risk factors may correlate with the challenge of achieving the high standard required for RCT.These insights contribute not only to improve education but also aid practitioners in treatment planning and referral decision-making within the field of endodontics.

Result Analysis
Print
Save
E-mail